the WHO world health organization scientist said the gliphosate can produce cancer, and monsanto scientist said is not true, so if the scientist against gmos are showing their studies and researches specially UN scientist why we should believe in monsanto scientist who are just working for money and profit? its not more scientific to believe in those who are showing their research work and no hiding or making it as confidential like monsanto does?

Expert response from Community Manager

Friday, 11/12/2015 12:43

Four programs within the World Health Organization (WHO) have reviewed glyphosate, and only one program, the International Agency for Research on Cancer (IARC), classified glyphosate as a “probable carcinogen.” This classification is not only inconsistent with the other WHO programs, but also with regulatory agencies around the world.   No regulatory agency, including the U.S. EPA or EFSA, has determined that there is a cancer risk with glyphosate used according to the label.  The recent announcement by the European Food Safety Authority (EFSA) is just the latest example of a science-based regulatory conclusion on glyphosate safety that contrasts the IARC classification.  In that review, EFSA considered studies published in the peer-review literature and also considered multiple long-term studies submitted by all registrants of glyphosate in Europe.  Their conclusions were based on a weight of the evidence evaluation that included all of the data. The EFSA conclusion builds upon the Canadian Pest Management Regulatory Agency preliminary reevaluation decision issued in April 2015. 

To better understand how IARC arrived at such an inconsistent conclusion on glyphosate, Monsanto retained Intertek Scientific & Regulatory Consultancy to convene an expert panel – made up of medical doctors and cancer experts, and experts in public health – to review IARC’s assessment. The expert panel’s findings are consistent with the recent EFSA conclusion that “glyphosate is unlikely to pose a carcinogenic hazard to humans”; the determination of the PMRA that “the overall weight of evidence indicates that glyphosate is unlikely to pose a human cancer risk”; and a recent statement from the U.S. EPA that a set of 55 epidemiological studies “does not provide evidence to show that glyphosate causes cancer.”  The expert panel also found that the IARC animal bioassay and genotoxicity evaluations “suffered from significant weaknesses such as: selectivity in the choice of data reviewed, failure to use all relevant biologic information to evaluate relationship to treatment in animal bioassays, and failure to use weight-of-evidence (WOE) evaluations using all available data and appropriate weighting.”

The regulatory review process for pesticides is rigorous and designed to ensure transparency. In most cases, after a thorough review of the data by the regulatory agencies, the detailed regulatory assessments are publicly available.  The submitted data are often accessible along with the assessment or through open records laws. Proprietary information submitted to regulatory agencies is not routinely released to the public. In many cases, Monsanto has moved to publish previously confidential information in the interest of transparency.   If you’re interested in exploring some of the publicly available literature relevant for the safety evaluation of glyphosate, here is a good resource.

I hope this information was helpful. 

Expert response from Community Manager

Friday, 11/12/2015 12:43

Four programs within the World Health Organization (WHO) have reviewed glyphosate, and only one program, the International Agency for Research on Cancer (IARC), classified glyphosate as a “probable carcinogen.” This classification is not only inconsistent with the other WHO programs, but also with regulatory agencies around the world.   No regulatory agency, including the U.S. EPA or EFSA, has determined that there is a cancer risk with glyphosate used according to the label.  The recent announcement by the European Food Safety Authority (EFSA) is just the latest example of a science-based regulatory conclusion on glyphosate safety that contrasts the IARC classification.  In that review, EFSA considered studies published in the peer-review literature and also considered multiple long-term studies submitted by all registrants of glyphosate in Europe.  Their conclusions were based on a weight of the evidence evaluation that included all of the data. The EFSA conclusion builds upon the Canadian Pest Management Regulatory Agency preliminary reevaluation decision issued in April 2015. 

To better understand how IARC arrived at such an inconsistent conclusion on glyphosate, Monsanto retained Intertek Scientific & Regulatory Consultancy to convene an expert panel – made up of medical doctors and cancer experts, and experts in public health – to review IARC’s assessment. The expert panel’s findings are consistent with the recent EFSA conclusion that “glyphosate is unlikely to pose a carcinogenic hazard to humans”; the determination of the PMRA that “the overall weight of evidence indicates that glyphosate is unlikely to pose a human cancer risk”; and a recent statement from the U.S. EPA that a set of 55 epidemiological studies “does not provide evidence to show that glyphosate causes cancer.”  The expert panel also found that the IARC animal bioassay and genotoxicity evaluations “suffered from significant weaknesses such as: selectivity in the choice of data reviewed, failure to use all relevant biologic information to evaluate relationship to treatment in animal bioassays, and failure to use weight-of-evidence (WOE) evaluations using all available data and appropriate weighting.”

The regulatory review process for pesticides is rigorous and designed to ensure transparency. In most cases, after a thorough review of the data by the regulatory agencies, the detailed regulatory assessments are publicly available.  The submitted data are often accessible along with the assessment or through open records laws. Proprietary information submitted to regulatory agencies is not routinely released to the public. In many cases, Monsanto has moved to publish previously confidential information in the interest of transparency.   If you’re interested in exploring some of the publicly available literature relevant for the safety evaluation of glyphosate, here is a good resource.

I hope this information was helpful.